Literature DB >> 30453349

Treatment Persistence in Atrial Fibrillation: The Next Major Hurdle.

Elaine M Hylek1.   

Abstract

Georg Thieme Verlag KG Stuttgart · New York.

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 30453349     DOI： 10.1055/s-0038-1676101

Source DB:  PubMed          Journal:  Thromb Haemost        ISSN： 0340-6245            Impact factor:   5.249


  4 in total

1.  Comparative effectiveness and safety of direct oral anticoagulants versus vitamin K antagonists in nonvalvular atrial fibrillation: a Canadian multicentre observational cohort study.

Authors:  Madeleine Durand; Mireille E Schnitzer; Menglan Pang; Greg Carney; Sherif Eltonsy; Kristian B Filion; Anat Fisher; Min Jun; I Fan Kuo; Christel Renoux; J Michael Paterson; Jacqueline Quail; Alexis Matteau
Journal:  CMAJ Open       Date:  2020-12-18

Review 2.  Methodological considerations for investigating oral anticoagulation persistence in atrial fibrillation.

Authors:  Miney Paquette; Lawrence Mbuagbaw; Alfonso Iorio; Robby Nieuwlaat
Journal:  Eur Heart J Cardiovasc Pharmacother       Date:  2021-05-23

Review 3.  Atrial Fibrillation in Older People: Concepts and Controversies.

Authors:  Zafraan Zathar; Anne Karunatilleke; Ameenathul M Fawzy; Gregory Y H Lip
Journal:  Front Med (Lausanne)       Date:  2019-08-08

4.  Optimizing adherence and persistence to non-vitamin K antagonist oral anticoagulant therapy in atrial fibrillation.

Authors:  José Maria Farinha; Ian D Jones; Gregory Y H Lip
Journal:  Eur Heart J Suppl       Date:  2022-02-14       Impact factor: 1.803
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.